Watkin Jones PLC (WJG)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 15.20 |
|---|---|
| 52-week range | 14.52 – 34.95 |
| Return, 1 month / 3 months | +0.0% / −17.4% |
| Return, 1 year / 3 years | −49.3% / −57.8% |
| Trend | Below its 200-day average |
| RSI (14) | 47 |
| Volatility (1 year) | 36.8% |
| Worst drawdown (1 year) | -57.0% |
| Average daily value traded | 18.00M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Watkin Jones is a property development and construction group based in the United Kingdom. It builds purpose-built student accommodation, private rented sector homes and residential schemes, and it also provides construction and development services. Its customers include institutional investors and property operators who fund and own the completed buildings, and the group works across a range of towns and cities in the country. The business covers the whole process from finding sites through to design, construction and handover of finished developments.
Watkin Jones PLC trades under the code WJG on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Watkin Jones PLC (WJG) trades on the London Exchange in UK. It last closed at GBX 15.20 on 23 October 2026.
Its price-based Market X-Ray is 27 out of 100 (a weak price profile), ranking 3,213 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 49.3% and over the last three months it fell 17.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 8 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -31.1% | ||
| From 52-week high | -55.8% | ||
| Momentum | 10 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.4% | ||
| 6-month return | -34.5% | ||
| 12-month return, skipping the last month | -49.3% | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 36.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.0% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 18.00M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.7% |
|---|---|
| 1 month | +0.0% |
| 3 months | −17.4% |
| 6 months | −34.5% |
| 1 year | −49.3% |
| 3 years | −57.8% |
| 5 years | −92.7% |
Signals
| 50-day / 200-day average | 15.92 / 22.06 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Jun 2023 | GBP 0.0140 |
| 2 Feb 2023 | GBP 0.0450 |
| 9 Jun 2022 | GBP 0.0290 |
| 27 Jan 2022 | GBP 0.0560 |
| 10 Jun 2021 | GBP 0.0260 |
| 8 Jun 2021 | GBP 1.9389 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.